Tobacco smoking and nicotine neuropsychopharmacology: Some future research directions

Neuropsychopharmacology

Volumn 18, Issue 6, 1998, Pages 456-468

  Domino, Edward F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Addiction; Dependence; Dopamine release; MAO inhibition; Nicotine; Pharmacology; Reinforcement; Tobacco

Indexed keywords

ACETYLCHOLINE; NICOTINE; NICOTINIC RECEPTOR;

ADSORPTION; ARTICLE; DOPAMINE RELEASE; DRUG EFFECT; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RECEPTOR BINDING; SMOKING;

ANIMALS; HUMANS; NICOTINE; NICOTINIC AGONISTS; PSYCHOPHARMACOLOGY; RECEPTORS, NICOTINIC; SMOKING;

EID: 0031953997     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00193-0     Document Type: Article

References (184)

1. Abdulla FA, Calaminici M, Wonnacott S, Gray JA, Sinden JD, Stephenson JD Sensitivity of rat frontal cortical neurons to nicotine is increased by chronic administration of nicotine and by lesions of the nucleus basalis magnocellularis. Synapse. 21:1995;281-288.
2. Abdulla FA, Bradbury E, Calaminici M-R, Lippiello PM, Wonnacott S, Gray JA, Sinden JD Relationship between up-regulation of nicotine binding sites in rat brain and delayed cognitive enhancement observed after chronic or acute nicotinic receptor stimulation. Psychopharmacology. 124:1996;323-331.
3. 3H]-nicotine binding to intact and solubilized rat brain membranes and evidence for its noncholinergic nature. Life Sci. 27:1980;1307-1314.
4. Adler LE, Hoffer LJ, Griffith J, Waldo M, Freedman R Normalization of deficient auditory sensory gating in the relatives of schizophrenics by nicotine. Biol Psychiatry. 32:1992;607-616.
5. Adler LE, Pachtman E, Franks RD, Percevich M, Waldo MC, Freedman R Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry. 17:1982;639-654.
6. Adlkofer F, Thurau K Effects of Nicotine on Biological Systems, Advances in Pharmacological Sciences. 1985;Birkhäuser Verlag, Boston. pp 1-646.
7. Andersson F, Fuxe K, Agnati FL, Eneroth P Effects of acute central and peripheral administration of nicotine on ascending dopamine pathways in the male rat brain. Evidence for nicotine induced increases of dopamine turnover in various telencephalic dopamine nerve terminal systems. Med Biol. 59:1981;170-176.
8. Armitage AK, Dollery CT, George CF, Houseman TH, Lewis PJ, Turner DM Absorption and metabolism of nicotine from cigarettes. Br Med J. 4:1975;313-316.
9. Arnerić SP, Sullivan JP, Williams M Neuronal nicotinic acetylcholine receptors - Novel targets for central nervous system therapeutics. Bloom FE, Kupfer DJ Psychopharmacology. The Fourth Generation of Progress, chap 9:1995;95-110 Raven Press, New York.
10. Bacq ZM La transmission chimique des influx dans le systeme nerveaux autonome. Erg Physiol. 37:1935;82-185.
11. Balfour DJK Nicotine and the Tobacco Smoking Habit. International Encyclopedia of Pharmacology and Therapeutics, Section 114. 1984;Pergamon Press, New York. pp 1-221.
12. Bannon AW, Decker MW, Williams M, Arnerić SP Psychotherapeutic potential of selective neuronal nicotine acetylcholine receptor ligands. Domino EF Brain Imaging of Nicotine and Tobacco Smoking. 1995;311-334 P Books, Ann Arbor, NP.
13. Bauco P, Wise RA Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine. Examination of repeated treatment J Pharmacol Exp Ther. 271:1994;294-301.
14. Belwell MEM, Balfour DJK ; The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br J Pharmacol. 105:1992;849-856.
15. Benowitz NL (1990): Pharmacokinetic considerations in understanding nicotine dependence. In Bock G, Marsh J (eds), Ciba Foundation Symposium 152. New York, John Wiley & Sons, pp 186-209.
16. Benowitz NL, Jacob P Intravenous nicotine replacement suppresses nicotine intake from cigarette smoking. J Pharmacol Exp Ther. 254:1990;1000-1005.
17. 11C-nicotine vapor in the human airway as visualized by positron emission tomography. Clin Pharmacol Ther. 57:1995;309-317.
18. Berlin I, Said S, Speux-Varoquaux O, Olivares R, Launay J-M, Puech AJ Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry. 38:1995;756-761.
19. Boulton AA, Yu PH, Tipton KF Biogenic amine adducts, monoamine oxidase inhibitors and smoking. Lancet. 1:1988;114-115.
20. Bovet D, Bovet-Nitti F, Oliverio A Genetic aspects of learning and memory in mice. The study of differences among strains and individual subjects is a most promising topic in psychobiology. Science. 163:1969;139-149.
21. Brown DA, Docherty RJ, Halliwell JV Chemical transmission in the rat interpeduncular nucleus in vitro. J Physiol. 341:1983;655-670.
22. Changeaux JP, Galzi JL, Devillers-Thiery A, Bertrand D The functional architecture of the acetylcholine nicotine receptor explored by affinity labeling and site-directed mutagenesis. Q Rev Biophys. 25:1992;395-432.
23. Chini B, Clementi F, Hukovic N, Sher E Neuronal α-bungarotoxin receptors and the α5-nicotinic receptor subunit gene are expressed in neuronal and non-neuronal human cells lines. Proc Natl Acad Sci USA. 89:1992;1572-1576.
24. Clark AJ The Model of Action of Drugs on Cells. 1933;E. Arnold and Co, London.
25. Clarke PBS (1990): Mesolimbic dopamine activation - The key to nicotine reinforcement? In Bock G, Marsh J (eds), The Biology of Nicotine Dependence, Ciba Foundation Symposium 152. New York, John Wiley & Sons, pp 153-168.
26. Clarke PBS, Kumar R The effects of nicotine on locomotor activity in tolerant and nontolerant rats. Br J Pharmacol. 78:1983;329-337.
27. Clarke PBS, Kumar R Characterisation of the locomotor stimulation action of nicotine in tolerant rats. Br J Pharmacol. 80:1983;587-594.
28. Clarke PBS, Pert A Autoradiographic distribution of nicotine receptors in rat brain. Brain Res. 323:1984;390-395.
29. Clarke PBS, Pert A Autoradiographic evidence for nicotinic receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:1985;355-358.
30. Clarke PBS, Fu DS, Jakubovic A, Fibiger HC Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. J Pharmacol Exp Ther. 246:1988;701-708.
31. Clarke PBS, Hommer DW, Pert A, Skirboll LR Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol. 85:1985;827-835.
32. 125]-α-bungarotoxin. J Neurosci. 5:1985;1307-1315.
33. Clarke PBS, Quik M, Adlkofer F, Thurau K Effects of Nicotine on Biological Systems II. 1995;Birkhäuser Verlag, Advances in Pharmacological Sciences. Boston.
34. Collins AC, Miner LL, Marks MJ Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol Biochem Behav. 30:1988;269-278.
35. Conti-Tranconi BM, Hunkapiller MW, Lindstrom JM, Raftery A Subunit structure of the acetylcholine receptor from electophorus electricus. Proc Natl Acad Sci USA. 79:1982;6489-6493.
36. Corrigall WA Understanding brain mechanisms in nicotine reinforcement. Br J Addict. 86:1991;507-510.
37. Corrigall WA, Coen KM Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology. 99:1989;473-478.
38. Corrigall WA, Franklin KBJ, Coen KM, Clarke PBS The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology. 107:1992;285-289.
39. Dale HH The action of certain esters and ethers of choline and their relation to muscarine. J Pharmacol Exp Ther. 6:1914;147-190.
40. Damsma G, Day J, Fibiger HC Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. Eur J Pharmacol. 168:1989;363-368.
41. Deneau GA, Inoki R Nicotine self-administration in monkeys. Ann NY Acad Sci. 142:1967;277-279.
42. Deneris ES, Connolly J, Rogers SW, Duvoisin R Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol Sci. 12:1991;34-40.
43. Deutch AY, Holliday J, Roth RH, Chun LLY, Hawrot E Immuno-histochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc Natl Acad Sci USA. 84:1987;8697-8701.
44. Domino EF Neuropsychopharmacology of nicotine and tobacco smoking. Dunn WL Jr. Smoking Behavior. Motives and Incentives:1983;5-31 V.H. Winston and Sons, Washington, DC.
45. Domino EF Behavioral, electrophysiological, endocrine, and skeletal muscle actions of nicotine and tobacco smoking. Remond A, Izard C Electrophysiological Effects of Nicotine. 1979;133-146 Elsevier/North Holland Biomedical Press, Amsterdam.
46. Domino EF Brain Imaging of Nicotine and Tobacco Smoking. 1995;NPP Books, Ann Arbor. a.
47. Domino EF Significance of multiple nicotine cholinergic receptors for tobacco use. Domino EF Brain Imaging of Nicotine and Tobacco Smoking. 1995;1-12 NPP Books, Ann Arbor.
48. Domino EF, Lutz MP Tolerance to the effects of daily nicotine on rat bar pressing behavior for water reinforcement. Pharmacol Biochem Behav. 1:1973;445-448.
49. Domino EF, Ni LS, Zhang H (1998): Nicotine alone and in combination with dopamine agonists in MPTP induced hemiparkinsonian monkeys. J Pharmacol Exp Ther, in press.
50. Dworkin SI, Vrana SL, Broadbent J, Robinson JH Comparing the reinforcing effects of nicotine, caffeine, methylphenidate and cocaine. Med Chem Res. 2:1993;593-602.
51. Edwards FA, Gibb AJ, Colquhoun D ATP receptor-mediated synaptic currents in the central nervous system. Nature. 359:1992;144-147.
52. Ehlert FJ, Roeske WR, Yamamura HI Molecular biology, pharmacology, and brain distribution of subtypes of the muscarinic receptor. Bloom FE, Kupfer DJ Psychopharmacology. The Fourth Generation of Progress, chap:1994;111-124 Raven Press, 10. New York.
53. Eissenberg G, Griffiths RR, Stitzer ML Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology. 127:1996;328-336.
54. Ejrup B The role of nicotine in smoking pleasure, nicotinism, treatment. von Euler US Tobacco Alkaloids and Related Compounds. 1965;333-346 Pergamon Press Book, New York. The Macmillan Co.
55. Essman WB Serotonin and monoamine oxidase in mouse skin. Effects of cigarette smoke exposure J Med. 8:1977;95-101.
56. Foulds J, Stapleton J, Feyerabend C, Vesey C, Jarvis M, Russell MAH Effect of transdermal nicotine patches on cigarette smoking. A double-blind crossover study Psychopharmacology. 106:1992;421-427.
57. Fowler JS, Volkow ND, Wang G-J, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R Inhibition of monoamine oxidase B in the brains of smokers. Nature. 379:1996;733-736.
58. Freedman R, Mirsky AF Event-related potentials. Exogenous components Steinhauser SR, Gruzelier JH, Zubin J Neuropsychology, Psychophysiology, and Information Processing. 1991;71-90 vol. 5. Amsterdam, Handbook of Schizophrenia. Elsevier.
59. Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia. Comparison of medicated and drug-free patients Biol Psychiatry. 18:1983;537-551.
60. Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM, Drebing C, Nagamoto H, Bickford-Wimer P, Franks R Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 13:1987;669-678.
61. Gause GF Analysis of various biological processes by the study of the differential action of optical isomers. Biodynamica. 3:1941;217-246.
62. Gause GF, Smaragdova NP Investigations on the toxicity of nicotine isomers in connection with some problems of the evolution of the CNS in animals. Biol Zh Arm. 7:1938;412-428.
63. Gause GF, Smaragdova NP On the killing action of optically isomeric nicotines in relation to problems of evolution of the nervous system in animals. Physiol Zool. 12:1939;238-255.
64. 2+ permeable α8 AChR functionally expressed in Xenopus oocytes exhibits significantly different pharmacology from α7 AChR. Soc Neurosci Abst. 23:1993;11.
65. Gilbert DG Smoking - Individual Differences, Psychopathology, and Emotion. 1995;Taylor and Francis, Washington, DC.
66. Gosselin RE Drug-receptor inactivation. A new kinetic model. In Von Rossum JM Kinetics of Drug Action. 1977;323-356 Springer Verlag, Berlin.
67. Green JT, Thomas GAO, Rhodes J, Evans BN, Russell MAH, Feyerabend C, Fuller GS, Newcombe RG, Sandborn WJ Pharmacokinetics of nicotine carbomer enemas. A new treatment modality for ulcerative colitis Clin Pharmacol Ther. 61:1977;340-348.
68. Grenhoff J, Svensson TH Selective stimulation of limbic dopamine activity by nicotine. Acta Physiol Scand. 133:1988;595-596.
69. Grenhoff J, Svensson TH Pharmacology of nicotine. Br J Addict. 84:1989;477-492.
70. Grenhoff J, Aston-Jones G, Svensson TH Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand. 128:1986;351-358.
71. Hakan RL, Hart C, Eyl C Specific neurophysiological effects of systemic nicotine on neurons in the nucleus accumbens. Synapse. 15:1993;191-197.
72. Hakan RL, Ksir CJ Nicotine induced locomotor activity in rats. The role of Pavlovian conditioning Pharmacol Biochem Behav. 29:1988;661-665.
73. Hakan RL, Ksir CJ Acute tolerance to the locomotor stimulant effect of nicotine in the rat. Psychopharmacology. 104:1991;386-390.
74. Henningfield JE, Jasinski DR Pharmacologic basis for nicotine replacement. Pomerleau OF, Pomerleau CS, Fagerström KO, Henningfield JE, Hughes JR Nicotine Replacement - A Critical Evaluation. 1988;35-61 Alan R Liss Inc, New York.
75. Henningfield JE, Miyasato K, Johnson RE, Jasinski DR Nicotine. Behavioral and physiological effects and self-administration in humans Pharmacol Biochem Behav. 15:1981;830.
76. Henningfield JE, Miyasato K, Jasinski DR Cigarette smokers self-administer intravenous nicotine. Pharmacol Biochem Behav. 19:1983;887-890.
77. Henningfield JE, Miyasato K, Jasinski DR Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther. 234:1985;1-12.
78. Henningfield JE, Goldberg SR, Jasinski DR Nicotine. Abuse liability, dependence potential and pharmacologic treatment of dependence Martin WR, VanLoon GR, Iwamoto ET, Davis L Tobacco Smoking and Nicotine - A Neurobiological Approach. 1987;81-99 Plenum Press, New York.
79. Henningfield JE, Stapleton JM, Benowitz NL, Grayson RF, London ED Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
80. Herxheimer A, Griffiths RL, Hamilton B, Wakefield M Circulatory effects of nicotine aerosol inhalations and cigarette smoking in man. Lancet. 2:1967;754-755.
81. Hildebrand BE, Nomikos CG, Bondjers C, Nisell M, Svensson TH Behavioral manifestations of the nicotine abstinence syndrome in the rat. Peripheral versus central mechanisms Psychopharmacology. 129:1997;348-356.
82. Imperato A, Mulas A, DiChiara G Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol. 132:1986;337-338.
83. Jarvik ME Biological influences on cigarette smoking. Krasnegor NA The Behavioral Aspects of Smoking, NIDA Research Monograph 26. 1979;7-45 US Government Printing Office, Washington, DC.
84. Jarvik ME Beneficial effects of nicotine. Br J Addict. 86:1991;571-575.
85. Jasinski DR, Henningfield JE Conceptual basis for replacement therapies for chemical dependence. Pomerleau OF, Pomerleau CS, Fagerström KO, Henningfield JE, Hughes JR Nicotine Replacement - A Critical Evaluation. 1988;13-34 Alan R Liss Inc, New York.
86. Jasinski DR, Johnson RE, Henningfield JE Abuse liability assessment in human subjects. Trends Pharmacol Sci. 5:1984;196-200.
87. Johnson DH Behavioral sensitization to nicotine. 1995;University of Göteborg, Ph.D. thesis. Sweden, pp 1-42.
88. Johnston LM Tobacco smoking and nicotine. Lancet. 2:1942;742.
89. Karlin A On the application of a "a plausible model" of allosteric proteins to the receptor for acetylcholine. J Theor Biol. 16:1967;306-320.
90. Katz B, Thesleff S A study of the "desensitization" produced by acetylcholine at the motor end-plate. J Physiol. 138:1957;63-80.
91. Keenan RM, Jenkins AJ, Cone EJ, Henningfield JE Smoked and i.v. nicotine, cocaine and heroin have similar abuse liability. Abstracts:1995;8th. Am Soc Addic MedNational Conference on Nicotine Dependence, Toronto, October 12-15.
92. Kenakin TP Pharmacologic Analysis of Drug-Receptor Interaction. 2:1993;Raven Press, New York.
93. Knott VJ Brain event-related potentials (ERPs) in smoking performance research. Ney T, Gale A Smoking and Human Behavior, chap. 1989;93-114 John Wiley and Sons, 5. New York.
94. 3H]acetylcholine to nicotinic receptors. Neuropharmacology. 24:1985;527-531.
95. Ksir C, Hakan RL, Kellar KJ Chronic nicotine and locomotor activity. Influences of exposure dose and test dose Psychopharmacology. 92:1987;25-29.
96. Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Hata K, Ichiyama A, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S Cloning sequencing and expression of the complementary DNA encoding the muscarinic acetylcholine receptor. Nature. 323:1986;411-416.
97. Lake JR, Upchurch TP, Shenoi M, Rajan N, Schweinle WE, Johnson SC, Malin DH Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-β-erythroidine (DHβE). Abst Soc Neurosci. 23:1997;257.
98. Larson PS, Silvette H (1968): Tobacco Experimental and Clinical Studies: A Comprehensive Account of The World Literature, Suppl. 1. Baltimore, Williams and Wilkins.
99. Larson PS, Silvette H (1971): Tobacco Experimental and Clinical Studies: A Comprehensive Account of the World Literature, Suppl 2. Baltimore, Williams and Wilkins.
100. Larson PS, Haag HB, Silvette H Tobacco Experimental and Clinical Studies. A Comprehensive Account of the World Literature:1961;Williams and Wilkins, Baltimore.
101. Leischow SJ, Nilsson F, Franzon M, Hill A, Otte P, Merikle EP Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav. 20:1996;264-371.
102. Lena C, Changeaux JP Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci. 16:1993;181-186.
103. Leutje CW, Patrick J Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J Neurosci. 11:1991;837-845.
104. Li CQ, Longmire AW, Kramer ED, Wright C Doses of nicotine replacement therapy (NRT). Clin Pharmacol Ther. 61:1997;190.
105. Lichtensteiger W, Hefti F, Felix D, Huwyler T, Melamed E, Schlumpf M Stimulation of nigrostriatal neurons by nicotine. Neuropharmacology. 21:1982;963-968.
106. Lindstrom J, Schoepfer R, Conroy WG, Whiting P (1990): Structural and functional heterogeneity of nicotinic receptors. In Bock G, Marsh J, (eds), The Biology of Nicotine Dependence, Ciba Foundation Symposium 152. New York, John Wiley & Sons, pp 23-52.
107. 3H]nicotine binding sites in the rat brain. Neurosci Lett. 53:1985;179-184.
108. Lucchesi BR, Schuster CR, Emley AB The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid. Pharmacol Ther. 8:1967;789-796.
109. McGehee DS, Heath MJS, Gelber S, Devay P, Role LW Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
110. Marks MJ, Collins AC Characterization of nicotine binding in mouse brain and comparison with the binding of α-bungarotoxin and quinuclidinyl benzilate. Mol Pharmacol. 22:1982;554-564.
111. Marks MJ, Romm E, Gaffney DK, Collins AC Nicotine-induced tolerance and receptor changes in four mouse strains. J Pharmacol Exp Ther. 237:1986;809-819.
112. Martin BR, Aceto MD Nicotine binding sites and their localization in the central nervous system. Neurosci Behav Rev. 5:1981;473-478.
113. Mereu G, Yoon KWP, Boi V, Gessa GL, Naes L, Westfall TC Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol. 141:1987;395-399.
114. Mesulam MM Structure and function of cholinergic pathways in the cerebral cortex, limbic system, basal ganglia, and thalamus of the human brain. Bloom FE, Kupker DJ Psychopharmacology. The Fourth Generation of Progress, chap:1994;135-146 Raven Press, 12. New York.
115. Molander L, Lunell E, Andersson SB, Kuylenstierna F Dose related and absolute bioavailability of nicotine from a nicotine vapor inhaler. Clin Pharmacol Ther. 59:1996;394-400.
116. Morrison CF Effects of nicotine on operant behavior of rats. Int J Neuropharmacol. 6:1967;229-240.
117. Morrison CJ, Stephenson JA The occurrence of tolerance to a central depressant action of nicotine. Br J Pharmacol. 46:1972;151-156.
118. Ney T, Gale A Smoking and Human Behavior. 1989;John Wiley & Sons, New York. pp 1-383.
119. Nisell M, Nomikos GG, Svensson TH Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
120. Nisell M, Nomikos GG, Svensson TH Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol. 76:1995;157-162.
121. Nisell M, Nomikos GG, Hertel P, Panagis G, Svensson TH Condition-independent sensitization of locomotor stimulation and mesocortical dopamine release following chronic nicotine treatment in the rat. Synapse. 22:1996;369-381.
122. Nisell M, Marcus M, Nomikos GG, Svensson TH Differential effects of acute and chronic nicotine on dopamine output in the core and shell of the rat nucleus accumbens. J Neural Transm. 104:1997;1-10.
123. Norman TR, Chamberlain KG, French MA, Burrows GD Platelet monoamine oxidase activity and cigarette smoking. J Affective Disorder. 4:1982;73-77.
124. Norman TR, Chamberlain KG, French MA Platelet monoamine oxidase. Low activity in cigarette smokers Psychiatry Res. 20:1987;199-205.
125. Numa S, Noda M, Takahashi H, Tanabe T, Toyosoto M, Furatani Y, Kikyotani S Molecular structure of the acetylcholine receptor. Cold Spring Harbor Symp Quant Biol. 48:1983;57-69.
126. Oreland L, Fowler CJ, Schalling D Low platelet monoamine oxidase activity in cigarette smokers. Life Sci. 29:1981;2511-2518.
127. Pankow JF, Mader BT, Isabelle LM, Luo W, Pavlich A, Liang C Conversion of nicotine in tobacco smoke to its volatile and available free-base form through the action of gaseous ammonia. Environ Sci Technol. 31:1997;2428-2433.
128. Paton WDM A theory of drug action based upon the rate of drug-receptor combination. Proc R Soc Lond (Biol). 154:1961;21-69.
129. Pomerleau CS Co-factors for smoking and evolutionary psychobiology. Addiction. 92:1997;397-408.
130. Popot JL, Sugiyama H, Changeaux JP Studies on the electrogenic action of acetylcholine with Torpedo Marmorate electric organ II. The permeability response of the receptor-rich membrane fragments to cholinergic agonists in vitro. J Mol Biol. 106:1976;469-483.
131. Porchet HC, Benowitz NL, Sheiner LB, Copeland JR Apparent tolerance to the acute effect of nicotine results in part from distribution kinetics. J Clin Invest. 80:1987;1466-1471.
132. Porchet HC, Benowitz NL, Xheiner LB Pharmacodynamic model of tolerance. Application to nicotine J Pharmacol Exp Ther. 244:1988;231-236.
133. Pratt WB, Taylor P Principles of Drug Action. The Basis of Pharmacology. 3:1990;Churchill Livingstone, New York.
134. Rand MJ, Thurau K The Pharmacology of Nicotine. 1988;ICSU Press by IRL Press, Washington, DC. pp 1-418.
135. Reiner PB, Fibiger HC Functional heterogeneity of central cholinergic systems. Bloom FE, Kupfer DJ Psychopharmacology. The Fourth Generation of Progress:1994;147-153 Raven Press, New York.
136. Richelson E Cholinergic transduction. Bloom FE, Kupfer DJ Psychopharmacology. The Fourth Generation of Progress, chap:1994;125-134 Raven Press, 11. New York.
137. Romano C, Goldstein A Stereospecific nicotine receptors on rat brain membranes. Science. 210:1980;647-650.
138. Rose JE, Levin ED Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict. 86:1991;605-609.
139. Rosecrans JA Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. Eur J Pharmacol. 14:1971;29-37.
140. Rosecrans JA The psychopharmacological basis of nicotine's differential effects on behavior. Individual subject variability in the rat Behav Genet. 25:1995;187-196.
141. Rosecrans JA, Stimler CA, Hendry JS, Meltzer LT Nicotine-induced tolerance and dependence in rat and mice. Studies involving schedule-controlled behavior Prog Brain Res. 79:1989;239-248.
142. Rosecrans JA, Karan LD, James JR Nicotine as a discriminative stimulus. Individual variability to acute tolerance and the role of receptor desensitization Clarke BPS, Quik M, Adlkofer F, Thurau K Effects of Nicotine on Biological Systems II. 1995;219-224 Birkhäuser Verlag, Basel.
143. Russell MAH, Stapleton JA, Feyerabend C Nicotine boost per cigarette as the controlling factor of intake regulation by smokers. Clarke PBS, Quik M, Adlkofer F, Thurau K Effects of Nicotine on Biological Systems II. 1995;233-238 Birkhäuser Verlag, Berlin.
144. Sargent PB The diversity of neuronal nicotinic acetylcholine receptors. Annu Rev Neurosci. 16:1993;403-443.
145. Schleifer LS, Eldefrawi ME Identification of the nicotinic and muscarinic acetylcholine receptors in subcellular fractions of mouse brain. Neuropharmacology. 13:1974;53-63.
146. Schmeltz I, Hoffmann D Chemical studies on tobacco smoke. Wynder EL, Hoffmann D, Gori B Modifying The Risk for the Smoker, vol I, chap. 38, DHEW Publication No. 76-1221. 1976;13-84 US Government Printing Office, Washington, DC.
147. 125]neuronal bungarotoxin. J Neurosci. 11:1991;287-297.
148. 3]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem. 45:1985;427-433.
149. 3H]acetylcholine in rat brain. Mol Pharmacol. 22:1982;56-62.
150. 3H]acetylcholine on catecholamine and serotonin axons in brain. J Neurochem. 42:1984;1495-1498.
151. Seguela P, Wadiche J, Dineley-Miller K, Dani JA, Patrick JW Molecular cloning, functional properties and distribution of rat brain α7. A nicotinic cation channel highly permeable to calcium J Neurosci. 13:1993;596-604.
152. 3H]nicotine to mouse brain. J Receptor Res. 2:1981;1-15.
153. Shoaib M, Schindler CW, Goldberg SR Nicotine self-administration in rats. strain and nicotine pre-exposure effects on acquisition Psychopharmacol. 129:1997;35-43.
154. - ion channels modulated by multiple drug-binding sites. Trends Pharmacol. 13:1992;446-450.
155. Silver AA, Sanberg PR Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Lancet. 342:1993;182.
156. 2 fraction. Psychopharmacol Bull. 19:1983;402-408.
157. 2 fraction. Pharmacol Biochem Behav. 20:1984;899-909.
158. 2 fraction. Pharmacol Biochem Behav. 23:1985;987-993.
159. 2 preparation. Life Sci. 37:1985;1367-1372.
160. 2 preparation. J Med Schem. 2228:1985;1245-1251.
161. Sloan JW, Martin WR, Smith WT Multiple nicotinic receptors. Nicotinic ligands with different specificities Martin WR, Van Loon GR, Iwamoto ET, Davis L Tobacco Smoking and Nicotine. 1987;451-465 Plenum Press, New York.
162. Sloan JW, Martin WR, Bostwick M, Hood R, Wala E The comparative binding characteristics of nicotine ligands and their pharmacology. Pharmacol Biochem Behav. 30:1988;255-267.
163. Smith CJ, Giacobini E Nicotine, Parkinson's and Alzheimer's disease. Rev Neurosci. 3:1992;25-42.
164. Steinbach JH (1990): Mechanism of action of the nicotinic acetylcholine receptor. In Bock G, Marsh J (eds), The Biology of Nicotine Dependence, Ciba Foundation Symposium 152. New York, John Wiley & Sons, pp 53-67.
165. Stephenson RPA A modification of receptor theory. Br J Pharmacol. 11:1956;379-393.
166. Stolerman IP Discriminative stimulus effects of nicotine in rats trained under different schedules of reinforcement. Psychopharmacology. 97:1989;131-138.
167. Stolerman IP, Fink R, Jarvik ME Acute and chronic tolerance to nicotine measured by activity in rats. Psychopharmacology. 30:1973;329-342.
168. Svensson TH, Grenhoff J, Enberg G (1990): Effects of nicotine on dynamic function of brain catecholaminergic neurons. In Bock G, Marsh J (eds), The Biology of Nicotine Dependence, Ciba Foundation Symposium 152. New York, John Wiley & Sons, pp 169-185.
169. Swanson LW, Simmons DM, Whiting PJ, Lindstrom J Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci. 7:1987;3334-3342.
170. Tarroni P, Rubboli F, Chini B Neuronal-type nicotinic receptors in human neuroblastoma and small-cell lung carcinoma cell lines. FEBS Lett. 312:1992;66-70.
171. Tessari M, Valerio E, Chiamulera C, Beardsley PM Nicotine reinforcement in rats with histories of cocaine self-administration. Psychopharmacology. 121:1995;282-283.
172. Thron GW On the analysis of pharmacological experiments in terms of an allosteric receptor model. Mol Pharmacol. 9:1973;1-9.
173. US Surgeon General's Report (1988): The Health Consequences of Smoking: Nicotine Addiction. Washington, DC, US Department of Health and Human Services, pp 1-639.
174. Vidal C Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex. New insight into the analysis of the role of nicotinic receptors in cognitive function Drug Dev Res. 31:1994;120-126.
175. Villaneuva S, Arezo JR, James JR, Rosecrans JA A characterization of nicotine-induced tolerance. Evidence of pharmacological tolerance in the rat Behav Pharmacol. 3:1992;255-260.
176. Wada E, Wada K, Boulter J, Deneris E, Heineman S, Patrick J, Swanson LW Distribution of alpha 2, alpha 3, and alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system. A hybridization histochemical study in the rat J Comp Neurol. 284:1989;314-335.
177. Waldo M, Carey G, Myles-Worsley M, Cawthra E, Adler LE, Nagamoto HT, Wender P, Byerley W, Plaetke R, Freedman R Codistribution of a sensory gating deficit and schizophrenia in multi-affected families. Psychiatry Res. 39:1991;257-268.
178. Winchell CJ, Wright C, Burke Let al. Long-term abstinence in users of OTC nicotine replacement. Clin Pharmacol Ther. 61:1997;191.
179. Wonnacott S The paradox of nicotinic acetylcholine receptor up-regulation by nicotine. Trends Pharmacol. 11:1990;216-219.
180. Wonnacott S Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
181. Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG Presynaptic modulation of transmitter release by nicotinic receptors. Nordberg A, Fuxe H, Holmstedt B, Sundwall A Progress in Brain Research. 1989;157-163 Elsevier, Amsterdam.
182. Yoshida K, Imura H Nicotinic cholinergic receptors in brain synaptosomes. Brain Res. 172:1979;453-459.
183. Yu PH, Boulton AA Irreversible inhibition of mono-amine oxidase by some components of cigarette smoke. Life Sci. 41:1987;675-682.
184. Zhang M, Wang YT, Vyas DM, Neuman RS, Bieger D Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus. Exp Brain Res. 96:1993;83-88.